SCHEMBL1288428

SCHEMBL1288428

O=C(O)CCCNC1CCCC1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.61
ALDH1A1 P00352 5/20 0.55
EPHX1 P07099 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.50
CXCR4 P61073 1/20 0.49
TAAR1 Q96RJ0 1/20 0.45
HTT P42858 1/20 0.43
HDAC3 O15379 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
NCOR2 Q9Y618 1/20 0.43
KDM4E B2RXH2 3/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
SIGMAR1 Q99720 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2677321 0.98 EPHX2 (0.64) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL16440004 0.98 EPHX2 (0.59) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL16440007 0.96 EPHX2 (0.62) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL16439978 0.96 EPHX2 (0.62) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL16439999 0.96 EPHX2 (0.62) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL12482731 0.96 EPHX2 (0.56) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL16439922 0.94 EPHX2 (0.54) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL5510947 0.92 EPHX1 (0.63) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL29952543 0.91 EPHX2 (0.50) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4
SCHEMBL20389857 0.91 EPHX2 (0.57) EPHX2ALDH1A1EPHX1SMN1; SMN2CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2661268-A2 INHIBITORS OF POLO-LIKE KINASE Elan Pharmaceuticals Inc. (US) 2013-11-13 EP disclosed
WO-2012048129-A2 INHIBITORS OF POLO-LIKE KINASE ELAN PHARMACEUTICALS, INC. (US) 2012-04-12 WO disclosed